Accretive Health (AH) Misses Q2 EPS by 5c; Slashes FY12 EPS Outlook
Tweet Send to a FriendGet Alerts AH Hot Sheet
Trade AH Now!
Accretive Health (NYSE: AH) reported Q2 EPS of $0.03, $0.05 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $236.7 million versus the consensus estimate of $234.64 million.
Sees FY2012 EPS of $0.23-$0.27, versus prior guidance of $0.42-$0.50 and the consensus of $0.41.
For earnings history and earnings-related data on Accretive Health (AH) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Sees FY2012 EPS of $0.23-$0.27, versus prior guidance of $0.42-$0.50 and the consensus of $0.41.
For earnings history and earnings-related data on Accretive Health (AH) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Applied Materials, Inc. (AMAT) Tops Q2 EPS by 3c, Offers Guidance
- Stage Stores, Inc. (SSI) Posts Surprise Q1 Loss of 2c/Share
- Cisco Systems (CSCO) Sees Q4 Revs Up 4% - 7%; EPS of 50c - 52c, Est. at 51c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
